Carpe Diem,

Was this the Arizona Alzheimer's study you were referring to? An oldie but a goodie.

My understanding is that Resverlogix is taking a wait and see approach with the BETonMACE cognition sub-study before diving in any further into cognition/dementia trials. As far as I know, they haven't disclosed any details for potential vascular cognitive dementia follow up trial(s) yet. But as you can tell from some of their recent posters, they are very interested in this space and have a stellar clinical steering committee. Resverlogix and the steering committee are likely ready to proceed if the cognition sub-study delivers promising results.

BearDownAZ